DrugPatentWatch Database Preview
Loxapine succinate - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for loxapine succinate and what is the scope of freedom to operate?
Loxapine succinate
is the generic ingredient in two branded drugs marketed by Elite Labs Inc, Lannett Co Inc, Mylan, Watson Labs, and Teva Branded Pharm, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for loxapine succinate. Seven suppliers are listed for this compound.
Summary for loxapine succinate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 5 |
| NDAs: | 8 |
| Drug Master File Entries: | 8 |
| Suppliers / Packagers: | 7 |
| Bulk Api Vendors: | 72 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,873 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for loxapine succinate |
| What excipients (inactive ingredients) are in loxapine succinate? | loxapine succinate excipients list |
| DailyMed Link: | loxapine succinate at DailyMed |
Recent Clinical Trials for loxapine succinate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mylan Pharmaceuticals | Phase 1 |
US Patents and Regulatory Information for loxapine succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | LOXITANE | loxapine succinate | TABLET;ORAL | 017525-007 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Lannett Co Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 090695-003 | Sep 26, 2011 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lannett Co Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 090695-001 | Sep 26, 2011 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lannett Co Inc | LOXAPINE SUCCINATE | loxapine succinate | CAPSULE;ORAL | 090695-002 | Sep 26, 2011 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for loxapine succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-004 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| Teva Branded Pharm | LOXITANE | loxapine succinate | CAPSULE;ORAL | 017525-003 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
